Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-01-27
2010-11-23
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07838678
ABSTRACT:
A process is provided for preparing the HIV protease inhibitor atazanavir bisulfate wherein a solution of atazanavir free base is reacted with concentrated sulfuric acid in an amount to react with less than about 15% by weight of the free base, seeds of Form A crystals of atazanavir bisulfate are added to the reaction mixture, and as crystals of the bisulfate form, additional concentrated sulfuric acid is added in multiple stages at increasing rates according to a cubic equation, to effect formation of Form A crystals of atazanavir bisulfate.A process is also provided for preparing atazanavir bisulfate as Pattern C material. A novel form of atazanavir bisulfate is also provided which is Form E3 which is a highly crystalline triethanolate solvate of the bisulfate salt from ethanol.
REFERENCES:
patent: 3980637 (1976-09-01), Grossman et al.
patent: 4022776 (1977-05-01), Nakagawa et al.
patent: 4800084 (1989-01-01), Zerbe
patent: 4847265 (1989-07-01), Badorc et al.
patent: 5158777 (1992-10-01), Abramowitz et al.
patent: 5428048 (1995-06-01), Malamas et al.
patent: 5489436 (1996-02-01), Hoy et al.
patent: 5541205 (1996-07-01), Malamas et al.
patent: 5849911 (1998-12-01), Fässler et al.
patent: 6086919 (2000-07-01), Bauer et al.
patent: 6087383 (2000-07-01), Singh et al.
patent: 6136345 (2000-10-01), Grimmett et al.
patent: 6316438 (2001-11-01), Yu et al.
patent: 6395767 (2002-05-01), Robl et al.
patent: 6414002 (2002-07-01), Cheng et al.
patent: 6653314 (2003-11-01), Cheng et al.
patent: 6670344 (2003-12-01), Venit et al.
patent: 6727271 (2004-04-01), Cheng et al.
patent: 6753012 (2004-06-01), Cappola
patent: 2002/0094992 (2002-07-01), MacLean
patent: 2004/0022855 (2004-02-01), Yoon et al.
patent: 2005/0214373 (2005-09-01), Desai et al.
patent: 2005/0256314 (2005-11-01), Kim et al.
patent: 2005/0266080 (2005-12-01), Desai et al.
patent: 2005/0288343 (2005-12-01), Rusowicz et al.
patent: 1 186 293 (2002-03-01), None
patent: 1 243 266 (2002-09-01), None
patent: WO 01/52825 (2001-07-01), None
patent: WO 02/085335 (2002-10-01), None
Goldstein, S.W. et al., “Hydroxyurea Derivatives as Hypoglycemic Agents”, J, Med. Chem., vol. 36, No. 15, pp. 2238-2240 (1993).
Malamas, M.S. at al., “Azole Phenoxy Hydroxyureas as Selective and Orally Active inhibitors of 5-Lipoxygenase”, J. Med. Chem., vol. 39, No. 1, pp. 237-245 (1996).
U.S. Appl. No. 11/119,551, filed May 2, 2005, Kim et al.
Earl, W.L. et al., “Measurement of13C Chemical Shifts in Solids”, Journal of Magnetic Resonance, vol. 48, pp. 35-54 (1982).
Johannsson, G. et al., “Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure”, Journal of Clinical Endocrinology and Metabolism, vol. 82, No. 3, pp. 727-734 (1997).
Jones, A.G. et al., “Programmed Cooling Crystallization of Potassium Sulphate Solutions”, Chemical Engineering Science, vol. 29, pp. 105-118 (1974).
Metz, G. et al., “Ramped-Amplitude Cross Polarization in Magic-Angle-Spinning NMR”, Journal of Magnetic Resonance, Series A, vol. 110, pp. 219-227 (1994).
Mullin, J.W. et al., “Programmed cooling of batch crystallizers”, Chemical Engineering Science, vol. 26, pp. 369-377 (1971).
Otwinowski, Z. et al., “Processing of X-Ray Diffraction Data Collected in Oscillation Mode”, Macromolecular Crystallography, Part A, Methods in Enzymology, vol. 276, Academic Press, publ., Carter, Jr., C.W. et al., eds., pp. 307-326 (1997).
Xu, Z. et al., “Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632”, Organic Process Research & Development, vol. 6, No. 3, pp. 323-328 (2002).
Yin, S. et al., “Simulated PXRD Patterns in Studies of the Phase Composition and Thermal Behavior of Bulk Crystalline Solids”, American Pharmaceutical Review, vol. 6, No. 2, pp. 80-85 (2003).
Davidovich Martha
Gougoutas Jack Z.
Kim Soo-jin
Lotz Bruce T.
Malley Mary F.
Bristol--Myers Squibb Company
Kumar Shailendra
Rodney Burton
LandOfFree
Process for preparing atazanavir bisulfate and novel forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing atazanavir bisulfate and novel forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing atazanavir bisulfate and novel forms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213124